ACADIA PHARMACEUTICALS INC COM STK USD0.0001 revenue for the last year amounted to 957.80 M USD, the most of which — 957.80 M USD — came from its highest performing source at the moment, Innovative Medicines, the year earlier bringing 726.44 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought ACADIA PHARMACEUTICALS INC COM STK USD0.0001 957.80 M USD, and the year before that — 726.44 M USD.